|1.||Dick, P: 4 articles (01/2003 - 04/2000)|
|2.||Ward, Tracy I: 3 articles (01/2012 - 05/2002)|
|3.||Wildman, Brian K: 3 articles (01/2012 - 05/2002)|
|4.||Jim, G Kee: 3 articles (01/2012 - 05/2002)|
|5.||Booker, Calvin W: 3 articles (01/2012 - 05/2002)|
|6.||Merrill, John K: 3 articles (01/2005 - 01/2004)|
|7.||Bagg, R: 3 articles (01/2003 - 04/2000)|
|8.||Schunicht, Oliver C: 2 articles (01/2012 - 12/2002)|
|9.||Berg, Janice: 2 articles (04/2009 - 01/2008)|
|10.||Hendrick, Steven: 2 articles (04/2009 - 01/2008)|
01/01/1998 - "These experiments suggest that tilmicosin is effective in the treatment of MG infections when administered in drinking water. "
12/01/2002 - "The objective of this study was to compare the efficacy of an intramammary infusion, containing tilmicosin phosphate, to an infusion of a negative control intramammary placebo for preventing new intramammary infections (IMI) during the dry period. "
12/01/2002 - "The efficacy of intramammary tilmicosin at drying-off, and other risk factors for the prevention of new intramammary infections during the dry period."
01/01/2004 - "The efficacy of tilmicosin administered in the feed to control Actinobacillus pleuropneumoniae infections in pigs was evaluated through a multisite, multitrial study. "
01/01/2003 - "The objective ofthis study was to evaluate the efficacy of intramammary tilmicosin, administered at drying-off, for eliminating Staphylococcus aureus infection, and to identify risk factors for S. "
06/15/1998 - "Fever-based and metaphylactic treatment programs that used tilmicosin decreased the prevalence of BRD and improved growth of calves. "
06/15/1998 - "To evaluate effects of tilmicosin when used in fever-based and metaphylactic treatment programs to attenuate acute undifferentiated bovine respiratory disease (BRD) in cattle that recently arrived at feedlots, and to evaluate the effects of tilmicosin for the treatment of BRD. "
06/15/1998 - "Cattle in the fever-based treatment group were given tilmicosin (10 mg/kg [4.5 mg/lb] of body weight, s.c.) during processing when their rectal temperature was > or = 40 C (104 F). "
03/01/1999 - "A field trial was performed under commercial feedlot conditions in western Canada to compare the efficacy of florfenicol and tilmicosin for the treatment of undifferentiated fever (UF) in calves that received metaphylactic tilmicosin upon arrival at the feedlot. "
05/01/2002 - "In Study 1 and in the combined analysis, the initial undifferentiated fever (UF) treatment rate was significantly (P < 0.05) higher in the oxytetracycline group as compared with the tilmicosin group. "
01/01/1993 - "These results suggest that treatment with a single dose of tilmicosin is effective in most cases of calf pneumonia caused by bacteria."
02/01/1996 - "The clinical field trials reported here confirm that tilmicosin in the feed at 200 micrograms/g is effective for control of swine pneumonia attributable to A pleuropneumoniae or P multocida. "
02/01/1996 - "Data indicate that tilmicosin phosphate fed to pigs at 200 to 400 micrograms/g is effective in controlling and preventing A pleuropneumoniae-induced pneumonia, when administered in feed for 21 days."
02/01/1996 - "To determine and evaluate the efficacy of the dose range of tilmicosin phosphate fed to pigs for control of pneumonia attributable to Actinobacillus pleuropneumoniae during episodes of clinical disease in commercial herds. "
02/01/1996 - "Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine."
01/01/2012 - "SLN significantly enhanced the therapeutic efficacy of tilmicosin determined by lower CFU counts and a decreased degree of inflammation. "
09/01/2000 - "As phagocytic clearance of apoptotic neutrophils by macrophages contributes to the resolution of inflammation, phagocytosis of tilmicosin-treated neutrophils by esterase-positive cultured bovine macrophages was assessed with light microscopy and transmission electron microscopy. "
01/01/2002 - "Recent studies indicate that in addition to being bactericidal, tilmicosin is capable of modulating inflammation in the lung. "
10/01/2000 - "In lesional lung tissues from animals that had received tilmicosin, we found large areas with limited inflammation. "
06/01/1999 - "Tilmicosin accumulates in the lungs, and infection/inflammation further improves its tissue penetration."
02/01/1996 - "Improvement in clinical impression score, daily rectal temperature, and weight gain were seen for all doses of tilmicosin, compared with controls. "
01/01/2004 - "With tilmicosin treatment, the average daily weight gain, daily temperature, abdominal appearance, attitude, and respiration were also significantly better (P < 0.05). "
02/01/1996 - "In trials with confirmed pneumonia caused by A pleuropneumoniae or Pasteurella multocida, weight gain, feed conversion, and clinical impression scores were significantly improved in the pigs receiving 200 or 400 micrograms/g of tilmicosin, compared with nonmedicated pigs. "
|6.||Anti-Bacterial Agents (Antibiotics)
|7.||flunixin meglumine (Banamine)
|9.||Dihydrostreptomycin Sulfate (Dihydrostreptomycin)
|10.||Dihydrotachysterol (AT 10)